76 unknown. 76 Phase 3, 25 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 76 | Unknown 76 |
| Phase 2 | 25 | Unknown 25 |
Follow Ischemia: new trials by email Literature Review of Ischemia trials Research Report on Ischemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute | Phase 2 / Phase 3 | Unknown | Capital Medical University | 302 | 2024-11-20 | 2024-10-29 |
| Efficacy of Using 50 ml Syringe Manual Thrombectomy Catheter in Primary PCI With Heavy Thrombus Burden 30 mL syringe manual thrombectomy catheter, 50 mL syringe manual thrombectomy catheter - STEMI - ST Elevation Myocardial Infarction, Thrombosis Cardiac | Phase 3 | Unknown | Helwan University | 88 | 2024-04-01 | 2024-03-26 |
| Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction Dutogliptin + Filgrastim, Placebo - ST Elevation Myocardial Infarction | Phase 3 | Unknown | Recardio, Inc. | 4100 | 2023-09-01 | 2023-06-05 |
| Umbilical Cord Mesenchymal Stem Cell Improve Cardiac Function on ST-elevation Myocardial Infarction (STEMI) Patients Umbilical Cord Mesenchymal Stem Cell transplantation - ST Elevation Myocardial Infarction | Phase 3 | Unknown | Universitas Indonesia | 60 | 2023-07-01 | 2023-07-07 |
| Prasugrel Or Ticagrelor De-escalation in NSTE-ACS De-escalation to ticagrelor 60 mg at day 30, De-escalation to prasugrel 5 mg at day 30, Switch to ticagrelor 60 mg at day 45 - Non ST Segment Elevation Acute Coronary Syndrome, Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) | Phase 3 | Unknown | Collegium Medicum w Bydgoszczy | 50 | 2023-04-01 | 2023-03-22 |
| Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT) Colchicine 0.5 MG Oral Tablet, Placebo - Coronary Artery Disease | Phase 3 | Unknown | Helwan University | 400 | 2023-03-01 | 2023-03-22 |
| EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction Empagliflozin 10 MG, Placebo - Myocardial Infarction | Phase 3 | Unknown | NHS Greater Glasgow and Clyde | 100 | 2022-09-16 | 2024-04-02 |
| Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support Ivabradine 7.5Mg Tab, DOBUTamine Injectable Solution - Heart Failure, Cardiogenic Shock | Phase 3 | Unknown | The Young Investigator Group of Cardiovascular Research | 200 | 2022-07-01 | 2022-10-26 |
| Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients Dapagliflozin - STEMI | Phase 3 | Unknown | Mohamed Nabil Elkholy | 120 | 2022-04-15 | 2024-04-16 |
| Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome Ticagrelor 90mg, Ticagrelor 60mg, Aspirin - STEMI, NSTEMI | Phase 3 | Unknown | Collegium Medicum w Bydgoszczy | 4500 | 2022-02-07 | 2023-04-21 |
| Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET) Metformin - PreDiabetes, Acute Myocardial Infarction | Phase 3 | Unknown | Karolinska Institutet | 5160 | 2021-12-02 | 2024-04-02 |
| The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction Sacubitril-Valsartan, Enalapril, Valsartan - STEMI | Phase 3 | Unknown | West China Hospital | 376 | 2021-11-01 | 2021-09-29 |
| Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction IVUS-guided PCI, Angiography-guided PCI - ST Elevation Myocardial Infarction | Phase 2 / Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 200 | 2021-10-01 | 2021-01-29 |
| Preventive VT Substrate Ablation in Ischemic Heart Disease Ventricular tachycardia substrate-based radiofrequency ablation - Ventricular Tachycardia, Ventricular Arrythmia | Phase 3 | Unknown | Centro Medico Teknon | 58 | 2021-06-01 | 2023-08-30 |
| Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial Infarction Dapagliflozin, Placebo - ST-segment Elevation Myocardial Infarction (STEMI), Diabetes Mellitus | Phase 3 | Unknown | Hospital Clinic of Barcelona | 54 | 2021-05-30 | 2025-02-19 |
| Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction lerodalcibep, Placebo - Cardiovascular Risk Factor, Cardiovascular Diseases | Phase 3 | Unknown | LIB Therapeutics LLC | 900 | 2021-04-22 | 2023-12-11 |
| Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI Atorvastatin, Aspirin - ST Elevation Myocardial Infarction | Phase 3 | Unknown | Assiut University | 160 | 2021-02-20 | 2021-02-15 |
| ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction Methoxyflurane - Penthrox, Morphine - ST Elevation Myocardial Infarction, Non ST Segment Elevation Acute Coronary Syndrome | Phase 3 | Unknown | Collegium Medicum w Bydgoszczy | 200 | 2020-06-01 | 2023-09-11 |
| Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant Rivaroxaban, Vitamin K Antagonist - ST Segment Elevation Myocardial Infarction, Left Ventricular Thrombus | Phase 3 | Unknown | RenJi Hospital | 280 | 2020-02-01 | 2023-06-01 |
| Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients. Apixaban, ASA, Clopidogrel 75mg - Critical Limb Ischemia | Phase 3 | Unknown | Science Valley Research Institute | 200 | 2020-01-09 | 2021-04-20 |
Showing 20 of 76. Sign in to see all of them.
ST Elevation Myocardial Infarction (25) · Myocardial Infarction (24) · Chronic Limb-Threatening Ischemia (9) · Heart Failure (9) · Cardiovascular Diseases (8) · Non-ST Elevated Myocardial Infarction (7) · Acute Coronary Syndrome (5) · Angina, Unstable (5) · Cerebral Infarction (5) · Peripheral Vascular Diseases (5) · Stroke (5) · Myocardial Ischemia (4) · Peripheral Arterial Disease (4) · Coronary Artery Disease (3)
Pathologic Processes (76) · Pathological Conditions, Signs and Symptoms (76) · Vascular Diseases (72) · Cardiovascular Diseases (67) · Necrosis (61) · Infarction (60) · Heart Diseases (55) · Myocardial Ischemia (52) · Myocardial Infarction (30) · Arterial Occlusive Diseases (14) · Arteriosclerosis (14) · Atherosclerosis (10) · Disease Attributes (10) · Chronic Disease (9)
Aspirin (5) · Dobutamine (3) · Transcranial Direct Current Stimulation (3) · dapagliflozin (3) · Atorvastatin (2) · Clopidogrel (2) · Doxycycline (2) · Rivaroxaban (2) · Simendan (2) · Sodium Chloride (2) · Ticagrelor (2) · Warfarin (2) · Abciximab (1) · Colchicine (1) · Constraint Induced Movement Therapy (1)
Collegium Medicum w Bydgoszczy (3) · Clinical Centre of Serbia (2) · Federal University of Paraíba (2) · Helwan University (2) · RenJi Hospital (2) · University Hospital, Antwerp (2) · ARYx Therapeutics (1) · American Heart of Poland (1) · Amsterdam UMC, location VUmc (1) · Anand, Sonia, M.D. (1) · Asklepios Kliniken Hamburg GmbH (1) · Assaf-Harofeh Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · Assuta Hospital Systems (1)
China (8) · United States (6) · France (5) · Poland (5) · Egypt (4) · Israel (4) · Italy (4) · Netherlands (4) · Spain (4) · Brazil (3) · Canada (3) · Germany (3) · United Kingdom (3) · Belgium (2) · Indonesia (2)
Adrian Corneliu Iancu, M.D, Ph.D (1) · Alberto Bouzas-Mosquera, MD (1) · Alex Blatt, MD (1) · Alfredo Zuppiroli, MD (1) · Anat Berkovitch, resident (1) · Andreas M Zeiher, MD (1) · Anna Norhammar, MD, Prof. (1) · Antonio Berruezo, MD, PhD (1) · Arafa Gomaa, MD (1) · Bambang Widyantoro, PhD (1) · Berthold Amann, MD (1) · Birgit Assmus, MD (1) · Chris A Glover, MD (1) · Chris Vrints, MD, PhD (1) · Dalip Sethi, PhD (1)
PMID 10811917, PMID 14578255, PMID 15007111, PMID 15861319, PMID 16168297, PMID 16337036, PMID 16644654, PMID 16916504, PMID 17138963, PMID 17315136, PMID 17634457, PMID 18502300, PMID 19490820, PMID 19700099, PMID 19858734, PMID 20012748, PMID 20298926, PMID 20373128, PMID 20417240, PMID 21567283, PMID 21981277, PMID 22067476, PMID 22319064, PMID 22406244, PMID 23047939, PMID 23410871, PMID 23668478, PMID 24395497, PMID 24485867, PMID 24631482, PMID 24746599, PMID 24934893, PMID 25425451, PMID 25458646, PMID 25739882, PMID 25791214, PMID 25854692, PMID 26324049, PMID 26347918, PMID 26420269, PMID 26498666, PMID 26796390, PMID 26822418, PMID 26861113, PMID 27677503, PMID 27679584, PMID 27814267, PMID 28096223, PMID 28286967, PMID 28411244
2017 (1), 2018 (1), 2019 (1)